{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:51:09Z","timestamp":1780638669311,"version":"3.54.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1023\/a:1015768114192","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T19:56:06Z","timestamp":1041105366000},"page":"41-49","source":"Crossref","is-referenced-by-count":34,"title":["Pathogenesis of degenerative retinopathies induced by thioridazine and other antipsychotics: a dopamine hypothesis"],"prefix":"10.1007","volume":"105","author":[{"given":"Pantaleo","family":"Fornaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Calabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Corallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni B.","family":"Picotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"392369_CR1","first-page":"198","volume":"13","author":"F. Inove","year":"1979","unstructured":"Inove F. Adverse reactions of antipsychotic drugs. Drug Intell Clin Pharm 1979; 13: 198\u2013208.","journal-title":"Drug Intell Clin Pharm"},{"issue":"4","key":"392369_CR2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2165\/00002018-199512040-00005","volume":"12","author":"T. Oshika","year":"1995","unstructured":"Oshika T. Ocular adverse effects of neuropsychiatric agents. Incidence and management. Drug Saf 1995; 12(4): 256\u201363.","journal-title":"Drug Saf"},{"key":"392369_CR3","doi-asserted-by":"crossref","unstructured":"Wettherholm DH, Snow HL, Winter FC. A clinical study of pigmentary change in cornea and lens in chronic Chlorpromazine therapy. Arch Ophthamol 1965; 55\u20136.","DOI":"10.1001\/archopht.1965.00970040057013"},{"key":"392369_CR4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.5694\/j.1326-5377.1966.tb72519.x","volume":"1","author":"ME. Cameron","year":"1966","unstructured":"Cameron ME. Skin and eye changes associated with Chlorpromazine therapy. Med J Aust 1966; 1: 478\u201380.","journal-title":"Med J Aust"},{"key":"392369_CR5","first-page":"190","volume":"1","author":"JR. Siddal","year":"1966","unstructured":"Siddal JR. Ocular toxic changes associated with Chlorpromazine and Thioridazine. Can J Ophtalmol 1966; 1: 190\u20138.","journal-title":"Can J Ophtalmol"},{"key":"392369_CR6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/bjo.51.2.86","volume":"51","author":"MBR. Mathalone","year":"1967","unstructured":"Mathalone MBR. Eye and skin changes in psychiatric patients treated with Chlorpromazine. Br J Ophthalmol 1967; 51: 86\u201393.","journal-title":"Br J Ophthalmol"},{"key":"392369_CR7","first-page":"311","volume":"3","author":"J Reboton Jr.","year":"1962","unstructured":"Reboton J Jr., Weak Ley RD, Bylenga ND, et al. Pigmentary retinopathy and iridocycloplegia in psychiatric patients. J Neuropsychiatry 1962; 3: 311\u20136.","journal-title":"J Neuropsychiatry"},{"key":"392369_CR8","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/jama.1959.03010110031006","volume":"170","author":"WJ. Kinross-Right","year":"1959","unstructured":"Kinross-Right WJ. Newer phenothiazine drugs in treatment of nervous disorders. J Am Med Assoc 1959; 170: 1283\u20138.","journal-title":"J Am Med Assoc"},{"key":"392369_CR9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archopht.1960.01840010067005","volume":"64","author":"RD Weekley","year":"1960","unstructured":"Weekley RD, Potts AM, Reboton J, May RH. Pigmentary retinopathy in patients receiving high doses of a new phenothiazine. Arch Ophthalmol 1960; 64: 95\u2013106.","journal-title":"Arch Ophthalmol"},{"key":"392369_CR10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archopht.1963.00960050777009","volume":"70","author":"AW. Scott","year":"1963","unstructured":"Scott AW. Retinal pigmentation in a patients receiving Thioridazine. Arch Ophthalmol 1963; 70: 775\u20138.","journal-title":"Arch Ophthalmol"},{"key":"392369_CR11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bjo.56.2.131","volume":"56","author":"ME Cameron","year":"1972","unstructured":"Cameron ME, Lawrence JM, Olrich JC. Thioridazine (Mellaril) retinopathy. Br J Ophthalmol 1972; 56: 131\u20134.","journal-title":"Br J Ophthalmol"},{"key":"392369_CR12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/archopht.1973.01000050253014","volume":"90","author":"FH. Davidorf","year":"1973","unstructured":"Davidorf FH. Thioridazine pigmentary retinopathy. Arch Ophthalmol 1973; 90: 251\u20135.","journal-title":"Arch Ophthalmol"},{"issue":"suppl.","key":"392369_CR13","first-page":"10","volume":"29","author":"JR. Siddal","year":"1968","unstructured":"Siddal JR. Ocular complications related to phenothiazines. Dis Nerv Syst 1968; 29(suppl.): 10\u20133.","journal-title":"Dis Nerv Syst"},{"key":"392369_CR14","first-page":"1054","volume":"70","author":"AM. Potts","year":"1960","unstructured":"Potts AM. Drug induced macular disease. Ophthalmol 1960; 70: 1054\u20137.","journal-title":"Ophthalmol"},{"key":"392369_CR15","first-page":"33","volume":"10","author":"V. Hagopian","year":"1966","unstructured":"Hagopian V. Pigmentary retinopathy due to Thioridazine or Mellaril. Kresge Eye Inst Bull 1966; 10: 33\u20139.","journal-title":"Kresge Eye Inst Bull"},{"issue":"10","key":"392369_CR16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0033-3182(85)72796-X","volume":"26","author":"JD. Hamilton","year":"1985","unstructured":"Hamilton JD. Thioridazine retinopathy within the upper dosage limit. Psychosomatics 1985; 26(10): 823\u20134.","journal-title":"Psychosomatics"},{"issue":"7","key":"392369_CR17","first-page":"737","volume":"132","author":"RW Lam","year":"1985","unstructured":"Lam RW, Remick RA. Pigmentary retinopathy associated with low dose Thioridazine treatment (Letter). Can Med Assoc J 1985; 132(7): 737.","journal-title":"Can Med Assoc J"},{"key":"392369_CR18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/archopht.1964.00970010832007","volume":"71","author":"MM Connell","year":"1964","unstructured":"Connell MM, Poley BJ, Mc Farlane JR. Chorioretinopathy associated with Thioridazine therapy. Arch Ophthalmol 1964; 71: 816\u201321.","journal-title":"Arch Ophthalmol"},{"key":"392369_CR19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/bjo.74.12.739","volume":"74","author":"MF. Marmor","year":"1990","unstructured":"Marmor MF. Is Thioridazine retinopathy progressive? Relationship of pigmentary changes to visual function. Br J Ophthalmol 1990; 74: 739\u201342.","journal-title":"Br J Ophthalmol"},{"key":"392369_CR20","first-page":"466","volume":"3","author":"PJ Leinfelder","year":"1964","unstructured":"Leinfelder PJ, Burian HM. Mellaril intoxication of retina with full restitution of function. Invest Ophthalmol Vis Sci 1964; 3: 466.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"392369_CR21","first-page":"522","volume":"1","author":"AM. Potts","year":"1962","unstructured":"Potts AM. The concentration of phenothiazines in the eye of experimental animals. Invest Ophthalmol Vis Sci 1962; 1: 522\u201330.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"392369_CR22","unstructured":"Bonnie AN. Progression of Thioridazine induced retinopathy. Brattleboro Retreat Psychiatry Rev 1992 (June)."},{"key":"392369_CR23","first-page":"74","volume":"37","author":"WS Bond","year":"1980","unstructured":"Bond WS, Yee SC. Ocular and cutaneous effects of chronic phenothiazine therapy. Am J Hosp Pharm 1980; 37: 74\u20138.","journal-title":"Am J Hosp Pharm"},{"key":"392369_CR24","first-page":"115","volume":"1","author":"P Fornaro","year":"1980","unstructured":"Fornaro P, Placidi GF, Cavallacci G, Perossini M & Castrogiovanni P. L'elettroretinografia come possibile metodo di studio nell'attivit\u00e0 dopaminergica nell'uomo. Riv Psichiatria 1980a; 1: 115\u20138.","journal-title":"Riv Psichiatria"},{"key":"392369_CR25","first-page":"293","volume":"4","author":"P Fornaro","year":"1980","unstructured":"Fornaro P, Castrogiovanni P, Perossini M Placidi GF, Cavallacci G. Electroretinography (ERG) as a tool of investigation in human psychopharmacology. Electroretinographic changes induced by a combination of Levo-DOPA and Carbi-DOPA. Acta Neurol 1980; 4: 293\u20139.","journal-title":"Acta Neurol"},{"key":"392369_CR26","first-page":"27","volume":"37","author":"M Perossini","year":"1982","unstructured":"Perossini M, Fornaro P, Wirth A. Recent advances on the origin and modulation of the b-wave of the electroretinogram. Atti Fond Giorgio Ronchi 1982; 37: 27\u201333.","journal-title":"Atti Fond Giorgio Ronchi"},{"key":"392369_CR27","first-page":"307","volume":"9","author":"P Fornaro","year":"1984","unstructured":"Fornaro P, Castrogiovanni P, Dell'Osso L, Perossini M, Placidi GF, Tassi G. Electroretinography (ERG) as a tool of investigation on dopaminergic activity in man. ERG changes induced by Perphenazine and Bromocriptine. Res Commun Psychol Psychiatr Behav 1984; 9: 307\u201323.","journal-title":"Res Commun Psychol Psychiatr Behav"},{"key":"392369_CR28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00140498","volume":"76","author":"P Bartel","year":"1990","unstructured":"Bartel P, Blom M, Robinson E, Van der Meiden C, Sommers D, Becker P. The effects of levodopa and haloperidol on flash and pattern ERG and VEPs in normal humans. Doc Opthalmol 1990; 76: 55\u201364.","journal-title":"Doc Opthalmol"},{"key":"392369_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00142587","volume":"75","author":"M Perossini","year":"1990","unstructured":"Perossini M, Fornaro P. Electroretinographic effects induced in humans by psychopharmacological agents. Doc Opthalmol 1990; 75: 1\u20139.","journal-title":"Doc Opthalmol"},{"key":"392369_CR30","unstructured":"Hanitzch R, Lichtenberger T. The origin of b-wave and slow potentials in the mammalian ERG. Int Soc Clin Electrofisiol Vis (ISCEV) 39th Congress, Naples, Italy; July, 1996; 26\u20139."},{"key":"392369_CR31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF01277947","volume":"97","author":"JB Zawilska","year":"1994","unstructured":"Zawilska JB, Derbiszewska T, Nowak JZ. Clozapine and other neuroleptic drugs antagonize the light-evoked suppression of melatonin biosynthesis in chick retina: involvement of the D4 dopamine receptor. J Neural Transm 1994; 97: 107\u20137.","journal-title":"J Neural Transm"},{"key":"392369_CR32","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1046\/j.1471-4159.1996.67062514.x","volume":"67","author":"J Nguyen-Legros","year":"1996","unstructured":"Nguyen-Legros J, Chanut E, Versaux-Botteri C, Simon A, Trouvin JH. Dopamine inhibits melatonin synthesis in photoreceptor cells through a D2-like receptor subtype in the rat retina: Biochemical and histochemical evidence. J Neurochem 1996; 67: 2514\u201320.","journal-title":"J Neurochem"},{"key":"392369_CR33","first-page":"201","volume":"49","author":"JB Zawilska","year":"1997","unstructured":"Zawilska JB, Nowak JZ. Dopamine D4-like receptors in vertebrate retina: does the retina offer a model for the D4 receptors analysis? Pol J Pharmacol 1997; 49: 201\u201311.","journal-title":"Pol J Pharmacol"},{"key":"392369_CR34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3940(00)01117-4","volume":"286","author":"G Tosini","year":"2000","unstructured":"Tosini G, Dirden JC. Dopamine inhibits melatonin release in the mammalian retina: in vitro evidence. Neurosci Lett 2000; 286: 119\u201322.","journal-title":"Neurosci Lett"},{"key":"392369_CR35","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0161-6420(82)34613-8","volume":"89","author":"FS Miller","year":"1982","unstructured":"Miller FS, Bunt-Milam AH, Kalina RE. Clinical ultrastructural study of Thioridazine retinopathy. Ophthalmology 1982; 89: 1478\u201388.","journal-title":"Ophthalmology"},{"key":"392369_CR36","first-page":"438","volume":"10","author":"SG. Kramer","year":"1971","unstructured":"Kramer SG. Dopamine: a retinal neurotransmitter. I. Retinal uptake, storage and lightstimulated release of 3H-Dopamine in the retina in vivo. Invest Opthalmol 1971; 10: 438\u201352.","journal-title":"Invest Opthalmol"},{"key":"392369_CR37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0006-8993(86)90396-3","volume":"374","author":"MA Zarbin","year":"1986","unstructured":"Zarbin MA, Wamslay JK, Palacios JM, Kuhar M. Autoradiographic localization of high affinity GABA, benzodiazepine, dopaminergic, adrenergic and muscarinic cholinergic receptors in the cat, monkey and human retina. Brain Res 1986; 374: 75\u201392.","journal-title":"Brain Res"},{"key":"392369_CR38","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.1073\/pnas.89.24.12093","volume":"89","author":"AI Cohen","year":"1992","unstructured":"Cohen AI, Todd RD, Harmon S, O'Malley KL. Photoreceptors of mouse retinal possess D4 receptors coupled to adenylate cyclase. Proc Natl Acad Sci USA 1992; 89: 12093\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"392369_CR39","first-page":"1620","volume":"33","author":"VT Tran","year":"1992","unstructured":"Tran VT, Dickman M. Differential localization of Dopamine D1 and D2 receptors in rat retina. Invest Opthalmol Vis Sci 1992; 33: 1620\u20136.","journal-title":"Invest Opthalmol Vis Sci"},{"key":"392369_CR40","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1471-4159.1986.tb00612.x","volume":"46","author":"A Dearry","year":"1986","unstructured":"Dearry A, Burnside B. Dopaminergic regulation of cone retinomotor movements in isolated teleost retina. I. Induction of cone contraction is mediated by D2 receptors. J Neurochem 1986; 46: 1006\u201321.","journal-title":"J Neurochem"},{"key":"392369_CR41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000468335","volume":"13","author":"V Filip","year":"1978","unstructured":"Filip V, Balik J. Possible indication of dopaminergic blockade in man by electroretinography. Int Pharmacopsychiatry 1978; 13: 151\u20136.","journal-title":"Int Pharmacopsychiatry"},{"key":"392369_CR42","first-page":"395","volume-title":"The retinal pigment epithelium","author":"KM Zinn","year":"1979","unstructured":"Zinn KM, Marmor MF. Toxicology of the human retinal pigment epithelium. In: Zinn KM, Marmor MF, eds. The retinal pigment epithelium. Cambridge, MA: Harvard University Press, 1979; 395\u2013412."},{"key":"392369_CR43","first-page":"148","volume-title":"Neuroretinal degenerations","author":"CHG. Botermans","year":"1972","unstructured":"Botermans CHG. Primary pigmentary degeneration and its association with neurological diseases. In: Vinken PJ, Bruyn GW, eds. Neuroretinal degenerations. Amsterdam: North-Holland, 1972; 148\u2013340."},{"key":"392369_CR44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0169-328X(94)00245-A","volume":"29","author":"M Matsumoto","year":"1995","unstructured":"Matsumoto M, Midaka K, Tada S, Tasaki Y, Yamaguchi J. Full length DNA and distribution of human dopamine D4 receptor. Mol Brain Res 1995; 29: 157\u201362.","journal-title":"Mol Brain Res"},{"key":"392369_CR45","unstructured":"Hawlina M, Ikeda H. Chronic treatment with Dopamine D2-agonist Bromocriptine prolongs functional survival of dystrophic RCS rat retinas. Int Soc Clin Electrophysiol Vis (ISCEV) 32th Symposium (abstract) Athens, Greece. June 1995; 26\u20139."},{"key":"392369_CR46","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1471-4159.1992.tb08466.x","volume":"59","author":"JZ Nowak","year":"1992","unstructured":"Nowak JZ, Kazula A, Golembiowska K. Melatonin increases serotonin-N-acetyltransferase activity and decreases dopamine synthesis in light-exposed chick retina: in vivo evidence supporting melatonin-dopamine interaction in retina. J Neurochem 1992; 59: 1499\u2013502.","journal-title":"J Neurochem"},{"key":"392369_CR47","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1139\/z76-054","volume":"54","author":"G Cheze","year":"1976","unstructured":"Cheze G, Ali MA. R\u00f4le de l'epiphyse dans la migration du pigment epithelial retinien chez quelques teleosteens. Can J Zool 1976; 54: 475\u201381.","journal-title":"Can J Zool"},{"key":"392369_CR48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01920634","volume":"35","author":"SF Pang","year":"1979","unstructured":"Pang SF, Yew DT. Pigment aggregation by melatonin in the retinal pigment epithelium and choroids of guinea pigs \u2018Cavia porcellus\u2019. Experientia 1979; 35: 231\u20133.","journal-title":"Experientia"},{"key":"392369_CR49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1085\/jgp.86.5.671","volume":"86","author":"ME Pierce","year":"1985","unstructured":"Pierce ME, Besharse JC. Circadian regulation of retinomotor movements. Interaction of melatonin and dopamine in the control of cone length. J Gen Physiol 1985; 86: 671\u201389.","journal-title":"J Gen Physiol"},{"key":"392369_CR50","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0014-4835(83)90051-9","volume":"36","author":"JC Bersharse","year":"1983","unstructured":"Bersharse JC, Dunis DA. Rod photoreceptor disc shedding in eye cups: relationship to bicarbonate and aminoacids. Exp Eye Res 1983; 36: 567\u201380.","journal-title":"Exp Eye Res"},{"key":"392369_CR51","first-page":"1894","volume":"33","author":"AF Weichman","year":"1992","unstructured":"Weichman AF, O'steen WK. Melatonin increases photoreceptor susceptibility to light damage. Invest Opthalmol Vis Sci 1992; 33: 1894\u2013902.","journal-title":"Invest Opthalmol Vis Sci"},{"key":"392369_CR52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0165-6147(94)90323-9","volume":"15","author":"P Seeman","year":"1994","unstructured":"Seeman P, Van Tol HH. Dopamine receptor pharmacology. Trends Pharmacol Sci 1994; 15: 265\u201370.","journal-title":"Trends Pharmacol Sci"},{"key":"392369_CR53","first-page":"2458","volume":"12","author":"T Sugawara","year":"1998","unstructured":"Sugawara T, Sieving PA, Iuvone PA, Bush R. The melatonin antagonist Luzindole protects retinal photoreceptors from light damage in the rat. Invest Opthalmol Vis Sci 1998; 12: 2458\u201365.","journal-title":"Invest Opthalmol Vis Sci"},{"key":"392369_CR54","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0014-4835(81)80003-6","volume":"32","author":"JPH Wise","year":"1981","unstructured":"Wise JPH, Lorscheider FL. Low retinal dopamine and serum prolactin levels indicate an inherited dopaminergic abnormality in BW rats. Exp Eye Res 1981; 32: 541\u201351.","journal-title":"Exp Eye Res"},{"key":"392369_CR55","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1600-0404.1979.tb02944.x","volume":"59","author":"H Shibasaki","year":"1979","unstructured":"Shibasaki H, Kato M, Inomata H, Nishimura M, Arakawa T, Kobayashi T, Nagara H, Kuroiwa Y. Pigmentary degeneration of the retina in heredodegenerative neurological diseases. Acta Neurol Scand 1979; 59: 331\u201342.","journal-title":"Acta Neurol Scand"},{"key":"392369_CR56","first-page":"347","volume":"1","author":"CJK Ellis","year":"1987","unstructured":"Ellis CJK, Allen TGJ, Marsden CD, Ikeda H. Electroretinographic abnormalities in idiopathic Parkinson's disease and the effect of levodopa administration. Clin Vis Sci 1987; 1: 347\u201355.","journal-title":"Clin Vis Sci"},{"key":"392369_CR57","first-page":"15","volume":"3","author":"N. Brunello","year":"1999","unstructured":"Brunello N. Meccanismi molecolari nell'azione dei nuovi farmaci antipsicotici. Quaderni Psichiatr 1999; 3: 15\u201323.","journal-title":"Quaderni Psichiatr"},{"key":"392369_CR58","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1021\/jm9708700","volume":"41","author":"L Cervetto","year":"1998","unstructured":"Cervetto L, Demontis GC, Giannaccini G, Longoni BM, Macchia B, Macchia R, Martinelli A, Orlandini E. N-n-Propyl-substituted 3-(dimethylphenyl) piperidines display novel discriminative properties between dopamine receptor subtypes: synthesis and receptor binding studies. J Med Chem 1998; 41: 4933\u20138.","journal-title":"J Med Chem"},{"key":"392369_CR59","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1016\/S0042-6989(97)00129-6","volume":"24","author":"MBA Djamgoz","year":"1997","unstructured":"Djamgoz MBA, Hankins MW, Hirano J, Archer R. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 1997; 24: 3509\u201329.","journal-title":"Vision Res"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015768114192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1015768114192\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015768114192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T03:57:47Z","timestamp":1753761467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1015768114192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["392369"],"URL":"https:\/\/doi.org\/10.1023\/a:1015768114192","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}